Evidence map›Paper›PMID 36210863›Full record

ArticleHeliyon2022

The development of coronaphobia scale and psychometric effect among UAE people.

Rasha Abdelrahman, Fouad Mohamed Aldawash

Erratum issuedAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rasha AbdelrahmanCollege of Humanities and Sciences, Ajman University, United Arab Emirates.
Fouad Mohamed AldawashDepartment of Psychology, College of Humanities and Sciences, A'Sharqiyah University, Ibra, Oman.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of the COVID-19 pandemic on mental health are likely to worsen as the epidemic progresses and will last long even after the pandemic has passed. The present study developed a coronaphobia scale during the pandemic to measure its psychological effects such as fear, anxiety, and depression in the majority of the cases in the United Arab Emirates (UAE). It is a 35-item scale that measures anxiety symptoms connected with COVID-19 and may be used to identify people who require mental health treatment. Based on 618 adults, the reliability and validity of these items were appropriate. The scales were distributed via social media using a Google form. Internal consistency, reliability analysis, and structural equation models, particularly confirmatory factor analysis, were carried out. The elevated scores on the coronaphobia scale were associated with social phobia, anxiety, stress, and depression. The coronaphobia score distinguishes well between those with and without dysfunctional anxiety (85% specificity and 90% sensitivity). These results support the coronaphobia scale as a valid and effective tool for clinical practice and research.

Indexed as

Coronaphobia scaleCOVID-19DevelopmentPsychometricUAE

Identifiers

PMID36210863
PMCPMC9531363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.